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OBJECTIVES Hepatocyte nuclear factor 4 gamma (HNF4G) is a protein
binding to a DNA element of the transthyretin promoter in pancreas,
kidney and small intestine. In a recent GWAS study, some SNPs in
HNF4Ggene are found to be associated with uric acid concentrations.
The aim of the present study was to assess the association between the
human HNF4G gene and hyperuricemia in Chinese Han population.
METHODS A total of 414 hyperuricemia patients and 406 gender and
age-matched normouricemic controls were enrolled. Four single-
nucleotide polymorphisms (SNPs) were genotyped as genetic markers
for the humanHNF4G gene (rs2977939, rs1805098, rs2941484,
rs4735692). Data were analyzed for three separate groups: the total
subjects, men, and women.
RESULTS For rs2941484 (SNP3), the genotype distribution in hyper-
uricemic subjects and was signiﬁcantly different from that in nor-
mouricemic controls in total subjects (P¼0.043) and men (P¼0.038).
Meanwhile, in recessive model of rs2941484, the distribution fre-
quency of TT genotype and CCþCT genotypes also showed the sig-
niﬁcant difference between the hyperuricemia patients and
normouricemic controls (P¼0.012 in total subjects and P¼0.011 in
men). In men, after adjustments for SBP, DBP, fasting glucose, total
cholesterol, triglycerides, LDL-C and creatinine, the people with the
TT genotype of rs2941484 were found to have signiﬁcantly higher
chance of suffering from hyperuricemia than the ones with CT and CC
genotypes (OR¼1.887, P ¼ 0.007).
CONCLUSIONS The results of this study indicate that the TT genotype
of rs2941484 in the human HNF4G gene might be a gender-speciﬁc
genetic marker for hyperuricemia in Chinese Han men.
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OBJECTIVES To study the effects of a atorvastatin on JNK/AP-1
signaling pathway and the expression of related factors in high
glucose concentration-induced vascular endothelial cells.
METHODS HUVECs cultured in vitro were divided into blank control
group(HG, 5.5mmol/L), the high glucose group(HG, 33 mmol/L), the
atorvastatin group (HG 33 mmol/Lþatrovastatin 10mmol/L). They were
cultured with relevant drugs for 48 h. The enzyme linked immuno-
sorbent assay (ELISA) was adopted to determine the content of TNF-a,
IL-6, ICAM-1 and VCAM-1, and pJNK, pcJUN and AP-1 protein ex-
pressions were determined by western blotting assay.
RESULTS Compared with blank control group, the content of TNF-a,
IL-6, ICAM-1 and VCAM-1 increased signiﬁcantly in HG group
(P<0.05), while pJNK, pcJUN and AP-1 protein expressions increased
(P < 0.05). Compared with HG group, the content of TNF-a, IL-6,
ICAM-1 and VCAM-1 in atorvastatin group decreased (P<0.05), while
pJNK, pcJUN and AP-1 protein expressions decreased (P<0.05).
CONCLUSIONS Atorvastatin can inhibit JNK/AP-1 signaling pathway
and the expression of related factors in high glucose concentration-
induced Vascular Endothelial Cells.
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OBJECTIVES Current renal denervation (RDN) procedures are criti-
cized for their lack of targeted energy delivery and their clinicaloutcome should be improved. We aimed to access an imaging-based
ablation strategy for RDN in hypertensive canine models using an
integrated ultrasound catheter.
METHODS An ultrasound imaging probe and acoustic ablation trans-
ducer were integrated in an 8 F catheter to provide renal-arterial
nerve ultrasonography and guided catheter-based acoustic RDN pro-
cedures. Ultrasonographic evaluation of renal innervation was con-
ducted in 27 hypertensive dogs. Three dogs were killed for histological
study, 20 were subjected to RDN using imaging-based site selection
and 4 underwent sham procedure. In the RDN group, 4 dogs were
killed immediately post RDN, while the rest were killed after 28 days
for pathologic examinations. The blood samples were collected for
further effects and safety evaluation in all animals before imaging and
sacriﬁced.
RESULTS All of animals survived the procedure. The renal nerves
exhibited linear-like echoes, and the distribution densities varied
signiﬁcantly across both the arterial regions and individual animals. In
the RDN group, 170 of the 256 ultrasonographically observed sites
with higher nerve densities were selected for ablation. An average
energy emission of 10.6 times was delivered to the bilateral renal ar-
tery. The BP signiﬁcantly decreased compared to the baseline (-12.6/-
9.1 mmHg, p <0.05) and to the sham group at 28 days post-ablation.
The plasma noradrenaline was decreased slightly but statistical
signiﬁcantly. The denervation effects were conﬁrmed by pathological
ﬁndings without signiﬁcant acoustic ablation-related complications.
CONCLUSIONS The ultrasound imaging-based RDN ablation can be
safely and effectively achieved in this hypertensive canine model.
Thus, the individualized strategy should be explored as a novel pro-
cedure for improving RDN in clinical practice.
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OBJECTIVES Diabetic patients suffer from serious neointimal hyper-
plasia following coronary interventions. The epigenetic abnormalities
are increasingly considered to be relevant to the pathogenesis of
diabetic complications. But the epigenetic mechanisms linking dia-
betes and coronary restenosis have not been fully elucidated. In this
study, we explored the protective effects and underlying mechanisms
of demethylases JMJD2A inhibition in balloon-injury induced neo-
intimal formation in diabetic rats.
METHODS The chemical inhibitor 2,4-pyridinedicarboxylic acid (2,4-
PDCA) and small interfering RNA (siRNA) were utilized to inhibit
JMJD2A. In vivo, diabetic rat model was induced using high-fat diet
(60% fat) and low-dose streptozotocin (35mg/kg). Diabetic rats un-
derwent common carotid artery balloon injury followed with local
transfection of siRNA-JMJD2A or intraperitoneal injection of 2,4-PDCA
(7.5 mg/kg/d). The neointimal formation was evaluated using hema-
tein-eosin (HE) staining. Immumohistochemical staining with speciﬁc
antibody to proliferating cell nuclear antigen (PCNA) and H3K9me3
were conducted to assess cellular proliferation and modiﬁcation of
H3K9me3 in vivo respectively. The inﬂammatory response was
detected using real-time PCR and western blot. In vitro, vascular
smooth muscle cells (VSMCs) were pre-treated with 2, 4-PDCA (1.0
mM) or transfected with siRNA-JMJD2A (20nM), followed by stimu-
lated by high glucose (HG). The proliferation and migration were
detected to evaluate the function of VSMCs in response to HG. Real-
time PCR and western blot were conducted to detect the expression of
inﬂammatory genes (MCP-1 and IL-6). Chromatin Immunoprecipita-
tion (ChIP) assay was performed to detect modiﬁcation of histone H3
lysine9 tri-methylation (H3K9me3) at promoters of MCP-1 and IL-6.
RESULTS Both in HG-stimulated VSMCs and balloon-injured arteries
of diabetic rats, JMJD2A was increased whereas H3K9me3 was
decreased. JMJD2A inhibition attenuated neointimal formation of
injured arteries in diabetic rats, in parallel with suppressed cellular
proliferation. Compared with injury group, the inﬂammatory response
(MCP-1 and IL-6) was repressed after JMJD2A inhibition, both in
mRNA and protein expression. Importantly, immumohistochemical
staining with anti-H3K9me3 indicated that there was elevated
H3K9me3 in neointimal VSMCs. Complementarily in vitro, JMJD2A
inhibition suppressed proliferation and migration in HG-stimulated
